MedEngine

04/12/2025

🇪🇺 MedEngine x Health-Ecore: Strengthening European impact together

Saku Torvinen and Cornelis Boersma from Health-Ecore share how our partnership unlocks seamless support across the and , broader real-world data access, and a unified approach to creating sustainable value for patients and societies.

Want to hear more? Let’s talk — message us or contact info@medengine.fi

02/12/2025

❓Pharma marketing compliance in the Nordics can be complex, but with the right partner it becomes clear and manageable.

At MedEngine, we offer tailored guidance that helps you understand Nordic requirements, plan launches and support stakeholder activities. Our combination of regulatory knowledge and scientific expertise ensures precise and credible advice, and our structured processes help make sure your communications meet local requirements every time.

Let’s talk — message us or contact info@medengine.fi.

27/11/2025

🇪🇺 MedEngine x Health-Ecore: A new partnership for stronger European impact

We’re excited to partner with Health-Ecore to strengthen our combined capabilities in market access, evidence generation, and health policy, expanding our impact across the Nordics, Benelux, and Europe.

Here are MedEngine’s COO and Market Access Director Saku Torvinen and Health-Ecore Founder & CEO Cornelis Boersma sharing why this collaboration matters in today’s complex healthcare landscape and how our complementary strengths help stakeholders create sustainable value for patients and societies.

Want to hear more? Let’s talk — message us or contact info@medengine.fi

24/11/2025

🔬 Clear, compliant communication across the Nordics

Effective marketing in the Nordic region requires more than understanding local regulations. It takes strategic insight, scientific credibility, and communication that consistently meets the highest ethical standards.

Our Nordic experts combine regulatory know-how with science-driven marketing experience to help you stay clear, compliant, and aligned with local codes throughout the entire product lifecycle.

Through our compliance and medical review services, we ensure every material meets legal, guideline, and industry standards while maintaining scientific accuracy and balance.

📲 Read more: https://www.medengine.fi/news/compliance-driven-excellence-in-pharmaceutical-marketing/

Contact us by a message or contact info@medengine.fi

At MedEngine, we help our clients navigate the Nordic compliance landscape with confidence.

21/11/2025

🔬 Turning complex science into real-world impact

At MedEngine, we help pharmaceutical teams cut through complexity with strategic, scientific, and creative support. Our work spans medical strategy, evidence generation, launch planning, market insights, and engaging content in all Nordic languages.

If you need stronger stakeholder engagement, a clearer scientific narrative, or support for your next launch, our team is ready to make it happen.

📲 Read more: https://www.medengine.fi/news/from-strategy-to-storytelling-excellence-in-medical-affairs-and-commercial-services/

Let’s talk — message us or contact info@medengine.fi

At MedEngine, we support pharmaceutical companies with strategic and scientific expertise, helping commercial and medical teams navigate today’s complex operational environment.

18/11/2025

📢 Creating compliant and credible pharma marketing materials requires expertise, and that’s where we can help!

At MedEngine, we provide regulatory and medical review across the Nordics. Our team ensures your materials follow local laws, guidelines and industry codes, while also checking scientific accuracy with PhD-level expertise. We tailor our support to your project, whether you need ongoing review or help with a specific set of materials, and our established processes keep quality consistently high.

Let’s talk — message us or contact info@medengine.fi.

13/11/2025

🎥 Turning expert insights into impactful content takes planning, precision, and a passion for science!

At MedEngine, we turn expert interviews and presentations into powerful tools for pharma—from shaping the story and filming with care to ensuring scientific accuracy and a smooth, enjoyable experience for every expert.

Want to make your experts shine or share your own insights on screen? Let’s talk, message us or contact info@medengine.fi.

11/11/2025

🔬 Join us for the 6th Nordic RWE and AI Conference in Helsinki!

We’re proud to announce that we are participating and presenting at the 6th Nordic RWE and AI Conference on 27-28 January 2026—A two-day, free-of-charge conference, gathering stakeholders from Nordic countries, EU and US to share advances in RWD, AI, regulatory, HTA and value-based healthcare.

📍 Location: University of Helsinki, Main Auditorium
🕒 Schedule: Tue 27 Jan from 12:00 to 17:45 & Wed 28 Jan from 09:00 to 15:30 (EET)
✅ Register: https://www.medengine.fi/6th-nordic-rwe-and-ai-conference-helsinki/

6th Nordic RWE and AI conference 27-28 January 2026, Helsinki

06/11/2025

Excited to present our latest research at ISPOR Europe 2025! 🏴󠁧󠁢󠁳󠁣󠁴󠁿✨

Next week in , our team will showcase three posters exploring access pathways and evidence generation across Finland and the Nordic region—all aimed at improving how innovative medicines reach patients.

🔹HTA196 – Implementation and Outcomes of Managed Entry Agreements Across the Nordic Region
Examining how Nordic countries apply managed entry agreements (MEAs) to balance affordability and access to new treatments.
📅 Tue 11 Nov | 🕥 10:30–13:30 GMT |📍Poster 3012

🔹HPR136 – Mapping Access Pathways for New Medicines in Finland
A real-world review of HTA and reimbursement decisions shaping the availability of new medicines in Finland.
📅 Tue 11 Nov | 🕓 16:00–19:00 GMT |📍Poster 2106

🔹HPR98 – Fragmentation in Access Pathways: A Review of HTA and Decision-Making Processes for Medicines in Finland
Analyzing structural and timeline differences in evaluations of outpatient and hospital medicines.
📅 Tue 11 Nov | 🕥 10:30–13:30 GMT |📍Poster 2056

We look forward to engaging with colleagues, exchanging insights, and advancing discussions on how real-world evidence and market access strategies can drive equitable healthcare across Europe.

📩 Let’s connect in Glasgow or continue the conversation afterwards. Please let us know, if you’re around: tero.ylisaukko-oja@medengine.fi | saku.torvinen@medengine.fi

See you in Glasgow! 👋

05/11/2025

🏴󠁧󠁢󠁳󠁣󠁴󠁿 Meet MedEngine at ISPOR Europe 2025!

Next week in Glasgow, we’re joining the global HEOR community to exchange insights, discuss real-world evidence, and explore the future of market access—and of course present our most recent work in the area.

Our team at the event: Tero Ylisaukko-oja — CEO & Founder & Saku Torvinen, PhD — COO & Market Access Director

If you’re attending ISPOR Europe and would like to connect, discuss collaborations, or share ideas — we’d love to meet you!

📩 Reach out to tero.ylisaukko-oja@medengine.fi or saku.torvinen@medengine.fi, or send us a message.

04/11/2025

Health-Ecore and MedEngine are joining forces to enhance market access and real-world evidence across Europe!

By combining Health-Ecore’s holistic expertise in healthcare strategy and policy with MedEngine’s market access and real-world evidence capabilities, we aim to create solutions that accelerate the future of care and deliver real impact for patients, healthcare systems, and societies.

The partnership was officially sealed today in Helsinki, marking the beginning of a journey to exchange insights, innovate together, and shape the future of market access in Europe.

📲 Read more: https://www.medengine.fi/news/health-ecore-and-medengine-join-forces/

Health-Ecore and MedEngine are joining forces in a new collaboration to enhance market access and real-world evidence solutions across Europe.

28/10/2025

💻🎉 Our webinar is TODAY! Still time to sign up: https://lnkd.in/dUhXiAGQ

MedEngine’s Scientific Consultant Mirkka Koivusalo will dive into how Nordic healthcare data can be leveraged to generate meaningful real-world evidence for pharma.